PharmExec Blog
Follow Us
RSS
Bookstore
Technology News- BioPharm News
- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
- Clinical Trials News
- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Sanofi Executive Change Up
Barely a week after former Glaxo executive Chris Viehbacher assumed the role of CEO, Sanofi-Aventis announced that Jean-Claude Leroy, the company’s executive vp of finance and legal, has left the company. In a short statement, the company noted that his position will be filled by two people, reporting directly to Viehbacher; they are CFO Laurence Debroux, and Karen Linehan, general counsel. So far, no one has commented as to the reason for Leroy’s departure.